Breaking

Zenobia Fairweather

Canada still struggles with chronic pain care
Daily Health

Canada still struggles with chronic pain care

Canada struggles with chronic pain care, affecting nearly eight million Canadians and costing over $43 billion annually, about chronic pain.

Zenobia Fairweather · November 21, 2026
Canada Increases Health Funding for Mental, Indigenous Care
Daily Health

Canada Increases Health Funding for Mental, Indigenous Care

Canada health funding in the 2026 budget adds $57.4 billion to the Canada Health Transfer, boosting mental-health, addiction and Indigenous care programs.

Zenobia Fairweather · November 19, 2026
AI and New Strategies Combat Rising Antibiotic Resistance
Drug Watch

AI and New Strategies Combat Rising Antibiotic Resistance

AI and new strategies are helping combat rising antibiotic resistance by analyzing genetic data to track superbugs and develop novel treatments.

Zenobia Fairweather · November 18, 2026
Canada’s Therapy Innovations Face Patient Access Hurdles
Drug Watch

Canada’s Therapy Innovations Face Patient Access Hurdles

Canada's therapy innovations face patient access hurdles, as a gap between scientific breakthroughs and healthcare coverage persists.

Zenobia Fairweather · November 17, 2026
Physicians get new networking platform
Daily Health

Physicians get new networking platform

Physicians get a new networking platform to maintain connections with colleagues across hospitals and organizations easily.

Zenobia Fairweather · November 14, 2026
Tirzepatide Reduces Asthma Flare-Up Risk in Diabetes Patients
Daily Health

Tirzepatide Reduces Asthma Flare-Up Risk in Diabetes Patients

Tirzepatide reduces asthma flare-up risk in diabetes patients, according to a study comparing it with semaglutide.

Zenobia Fairweather · November 12, 2026
Healthcare leaders push shift from perfection to learning
Clinic Briefs

Healthcare leaders push shift from perfection to learning

Healthcare leaders say shifting from a perfection mindset to a learning culture reduces fear of errors and promotes steady improvement in health…

Zenobia Fairweather · November 9, 2026
FDA to rule on Novo’s CagriSema soon
Clinic Briefs

FDA to rule on Novo’s CagriSema soon

The U.S. Food and Drug Administration is expected to issue its decision before the close of 2026 on whether to grant approval…

Zenobia Fairweather · November 6, 2026
FDA approves new hepatitis B treatment
Drug Watch

FDA approves new hepatitis B treatment

FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.

Zenobia Fairweather · November 4, 2026
FDA Approves Tildrakizumab for Psoriatic Arthritis
Drug Watch

FDA Approves Tildrakizumab for Psoriatic Arthritis

The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.

Zenobia Fairweather · November 3, 2026